Biotechnology is one of those sectors that is totally out of grace after it came down sharply in the second half of 2015, as market volatility rose sharply.
The first chart shows that the biotech index (represented by the IBB ETF) lost 40% of its value in just 7 months. Talking about a sharp correction! That could sound amazing but the more important conclusion is that the long term uptrend was not violated, as seen on the chart.
Interestingly, the biotech index is forming a huge triangle formation, with support at 250 and resistance at 300. On the daily chart, we see a declining trend channel, with the same resistance line as observed on the weekly, in particular, at 300 points, which is 10% above today’s closing price.
In other words, the biotech sector could have been trashed by many because of negative sentiment, but it is still too early to become pessimistic (or excited). There simply is no trend at this point, so more evidence is required, preferably in the form of a breakout or breakdown.
We picked out two amazingly interesting companies in the sector.
First, Amgen (AMGN) is in the process of a huge breakout! Watch a retest of the resistance line, after it broke out, for a confirmed buy signal.
A smaller company, Boston Scientific Corp (BSX), with a market cap of $26B, just rose to all-time highs today. Its chart pattern looks extremely strong, and it is certainly a buy as this is the third attempt to break through 14 month resistance.
CONCLUSION:
Biotech is not as bad as many believe you to be. Some companies are doing truly great. Stock picking is mandatory in this stage, until the biotech index shows a confirmed breakout, at which point “higher risk plays” in the sector will be justified.
Disclaimer: InvestingHaven.com makes every effort to ensure that the information ...
more
Disclaimer: InvestingHaven.com makes every effort to ensure that the information provided is complete, correct, accurate and updated.In spite of these efforts, errors may occur in the information provided.If the information provided contains errors or if certain information is not available on or via the site, InvestingHaven.com will make every effort to rectify the situation as soon as possible. However, InvestingHaven.com cannot be held liable for direct or indirect damages resulting from the use of the information on this site. If you notice any errors in the information provided via the site, please contact the manager of the site.
Moreover, the views expressed in the articles (posts) on this website are the ones from the authors and are for information only. It is not intended as an offer, invitation, or solicitation to buy or sell any of any security or asset described. Nor the website manager nor the authors do accept any liability whatsoever for any direct or consequential loss arising from the use of their content. Please consult a qualified financial advisor before making investments. The information on this website and in the articles (posts) is believed to be reliable , but the authors do not make any representations as to its accuracy or completeness.
The content of the site (including links) may be adjusted, changed or expanded at any time without notice. InvestingHaven.com does not guarantee the proper functioning of the website and cannot be held liable in any way for the improper functioning or temporary (un)availability of the website or for any form of damage, direct or indirect, which may be the result of access to or use of the website.
InvestingHaven.com cannot be held liable under any circumstances by anyone, directly or indirectly, in any specific or other way, for damages resulting from the use of this site or any other site connected by means of links or hyperlinks, including, without limitation, any losses, interruptions of work, damage to programmes or other information on the computer system or to equipment, software or other items owned by the user.
less
How did you like this article? Let us know so we can better customize your reading experience.